Literature DB >> 17239476

Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis.

Sara Montagnese1, Clive Jackson, Marsha Y Morgan.   

Abstract

BACKGROUND/AIMS: Slowing of the electroencephalogram (EEG) is a recognised feature of hepatic encephalopathy but its diagnostic sensitivity is indeterminate. Recent advances in EEG analysis should provide better quantifiable/more informative data. The aim of this study was to isolate and determine the scalp distribution of the posterior basic rhythm, in patients with cirrhosis, using a technique for spatio-temporal decomposition (SEDACA) of the EEG.
METHODS: One hundred and ten patients with cirrhosis, classified, using clinical and psychometric criteria, as neuropsychiatrically unimpaired or as having minimal/overt hepatic encephalopathy were studied. Eyes-closed, awake EEGs were obtained and subjected to standard spectral analysis and spatio-temporal decomposition. Control data were obtained from 26 reference EEGs.
RESULTS: The error in the estimate of the SEDACA-derived mean dominant frequency was lower than for the standard EEG derivation (P<0.00001). The SEDACA-derived spectral estimates correlated better with neuropsychiatric status and allowed differentiation of the patients with minimal hepatic encephalopathy from the reference population. The SEDACA-derived spatial information showed an anteriorization of the posterior basic rhythm, which became more prominent as the degree of neuropsychiatric impairment increased (P=0.00052).
CONCLUSIONS: Analysis of the EEG utilising SEDACA provides significantly more diagnostic information on the neuropsychiatric status of patients with cirrhosis than obtained conventionally.

Entities:  

Mesh:

Year:  2006        PMID: 17239476     DOI: 10.1016/j.jhep.2006.10.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

Review 1.  Diagnosis of minimal hepatic encephalopathy.

Authors:  Karin Weissenborn
Journal:  J Clin Exp Hepatol       Date:  2014-07-31

Review 2.  Current and future diagnosis of hepatic encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Metab Brain Dis       Date:  2010-03-06       Impact factor: 3.584

Review 3.  Pathogenesis, diagnosis, and treatment of hepatic encephalopathy.

Authors:  Dileep K Atluri; Ravi Prakash; Kevin D Mullen
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 4.  Useful tests for hepatic encephalopathy in clinical practice.

Authors:  Eiman Nabi; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2014-01

Review 5.  Where are we going? Translational research in hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Kevin Mullen; James G Orr; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2015-09-09       Impact factor: 3.584

Review 6.  Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

Authors:  J S Bajaj; J Cordoba; K D Mullen; P Amodio; D L Shawcross; R F Butterworth; M Y Morgan
Journal:  Aliment Pharmacol Ther       Date:  2011-02-09       Impact factor: 8.171

7.  Acute hyperammonaemia induces a sustained decrease in vigilance, which is modulated by caffeine.

Authors:  E P Casula; P S Bisiacchi; M Corrias; S Schiff; C Merkel; P Amodio; S Montagnese
Journal:  Metab Brain Dis       Date:  2014-07-24       Impact factor: 3.584

Review 8.  Therapeutic studies in hepatic encephalopathy.

Authors:  Kevin D Mullen; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 9.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

10.  Subanaesthetic ketamine and altered states of consciousness in humans.

Authors:  P E Vlisides; T Bel-Bahar; A Nelson; K Chilton; E Smith; E Janke; V Tarnal; P Picton; R E Harris; G A Mashour
Journal:  Br J Anaesth       Date:  2018-04-13       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.